Valo Health Partners with Merck on $3B Parkinson’s Disease Discovery Deal
Valo Health, Inc. announced a strategic collaboration with Merck KGaA (ETR: MRK) to advance therapeutic...
Valo Health, Inc. announced a strategic collaboration with Merck KGaA (ETR: MRK) to advance therapeutic...
Partners Novo Nordisk (NYSE: NVO) and Valo Health have announced an expanded partnership, aiming to...